Factors Such as the Rise in Prevalence of Central Nervous System Disorders and Advancements in Therapeutics and Diagnostics of Central Nervous System Disorders are Driving the Demand for the Global Central Nervous System Therapeutics Market.
Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The global central nervous system therapeutics market is segmented into drug class, application, route of administration, end user, distribution channels, regional distribution, and competitive landscape. Based on application, the market is fragmented into neurovascular diseases, mental health and trauma, neurodegenerative diseases, infectious diseases, cns cancer, and others. Neurodegenerative diseases are expected to capture the highest market share during the forecast period, 2023-2027. The high cost of treatment of neurodegenerative diseases and the increased prevalence of neurodegenerative diseases such as Parkinson’s disease, multiple sclerosis, and Alzheimer’s disease are driving the segment demand.
North America is expected to dominate the global central nervous system therapeutics market during the forecast period. The presence of key market players in the region and the initiatives taken by market players to develop new technologies are infleuncing the market demand. Also, the rising incidence of mental health conditions and neurological disorders is expected to propel the market demand in the forecast period.
The major market players operating in the global central nervous system therapeutics market are Eli Lilly and Company Ltd., Merck & Co. Inc., AstraZeneca PLC, Novartis AG, Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Biogen Inc., Pfizer Inc., GlaxoSmithKline PLC, Otsuka Holdings Co. Ltd., Johnson & Johnson Services Inc., Sanofi SA, Bristol Myers Squibb Pharmaceuticals Ltd., Bayer AG, Amgen Inc., among others.
Years considered for this report:
- Historical Years: 2017 - 2020
- Base Year: 2021
- Estimated Year: 2022
- Forecast Period: 2023 - 2027
Objective of the Study:
- To analyze and forecast the market size of Global central nervous system therapeutics market from 2017 to 2021.
- To estimate and forecast the market size of Global central nervous system therapeutics market from 2022 to 2027 and growth rate until 2027.
- To classify and forecast global central nervous system therapeutics market based on drug class, application, route of administration, end user, distribution channel, and regional distribution.
- To identify dominant region or segment in the global central nervous system therapeutics market.
- To identify drivers and challenges for global central nervous system therapeutics market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global central nervous system therapeutics market.
- To identify and analyze the profile of leading players operating in global central nervous system therapeutics market.
- To identify key sustainable strategies adopted by market players in global central nervous system therapeutics market.
The publisher calculated the market size of global central nervous system therapeutics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.
Key Target Audience:
- Central nervous system therapeutics manufacturers, end users, service providers and other stakeholders
- Distributers and suppliers of central nervous system therapeutics and services and other stakeholders
- Organizations, forums, and alliances related to central nervous system therapeutics
- Market research and consulting firms
Report Scope:
In this report, Global central nervous system therapeutics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:Market, By Drug Class:
- Analgesics
- Anesthetics
- Anticonvulsants
- Antiepileptics
- Anti-Parkinson Agents
- Others
Market, By Application:
- Neurovascular Diseases
- Mental Health and Trauma
- Neurodegenerative Diseases
- Infectious Diseases
- CNS Cancer
- Others
Market, By Route of Administrations:
- Oral
- Parenteral
- Others
Market, By End User:
- Hospitals
- Clinics
- Diagnostic Laboratories
- Others
Market, By Distribution Channel:
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Market, By Region:
- North America
- APAC
- Europe
- MEA
- South America
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Global central nervous system therapeutics market.Available Customizations:
With the given market data, the publisher offers customizations according to a company’s specific needs.This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Eli Lilly and Company Ltd.
- Merck & Co. Inc.
- AstraZeneca PLC
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
- F. Hoffmann-La Roche AG
- Biogen Inc.
- Pfizer Inc.
- GlaxoSmithKline PLC
- Otsuka Holdings Co. Ltd.
- Johnson & Johnson Services Inc.
- Sanofi SA
- Bristol Myers Squibb Pharmaceuticals Ltd.
- Bayer AG
- Amgen Inc.